Hypoalbuminemia
104 results
1 - 100
Hypoalbuminemia
Protein, total- Phenytoin
- Glomerulonephropathies
Nephrotic Syndrome- Protein-losing enteropathy
- Hypoparathyroidism
- Decreased anion gap
- Hypothyroidism
cobimetinib- elotuzumab
- etoposide
- lurbinectedin
- etoposide phosphate
- polatuzumab vedotin
- larotrectinib
- loncastuximab tesirine
- tepotinib
- irinotecan liposomal
- capmatinib
- moxetumumab pasudotox
- decitabine/cedazuridine
- denileukin diftitox
- Ascites
- dinutuximab
- adagrasib
- dacomitinib
- tagraxofusp
- avapritinib
- teclistamab
- fruquintinib
- tafasitamab
- talquetamab
- Calcium, serum or plasma
- duvelisib
- pemigatinib
- infigratinib
- elranatamab
- ensartinib
- tebentafusp
- Hypoparathyroidism
- daunorubicin/cytarabine liposomal
- naxitamab
- lorlatinib
- amivantamab
- futibatinib
- Nephritic Syndrome
- axitinib
- blinatumomab
- midostaurin
- alpelisib
- bezafibrate
- selumetinib
- sirolimus (protein bound)
- Kawasaki Disease
- Eating Disorders
- atezolizumab
- entrectinib
- mogamulizumab
- tisotumab vedotin
- mobocertinib
- mitoMYcin
- durvalumab
- pertuzumab/trastuzumab/hyaluronidase
- acitretin
- pegfilgrastim
- dostarlimab
- Hydrocele
- Glomerulonephritis
- Lactate
- Ascites (expanded list)
- tremelimumab
- Hypocalcemia
- trabectedin
- phenytoin
- ACID–BASE DISTURBANCE: LABORATORY CHARACTERISTICS OF PRIMARY OR SINGLE ACID–BASE DISTURBANCE
- decitabine
- Feeding Tube Complications
- FENTANYL (transmucosal)
- Acidosis
- PHARMACOKINETIC PARAMETERS
- aldesleukin
- gemcitabine